Novartis AG - ADR

NYSE:NVS   4:00:00 PM EDT
0.00 (0.00%)
: $100.10 +1.19 (+1.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)197.16B
Current PE28.05
Forward PE 14.59
2yr Forward PE 13.35
See more stats
Estimates Current Quarter
Revenue$13.39 Billion
Adjusted EPS$1.69
See more estimates
10-Day MA$98.80
50-Day MA$99.05
200-Day MA$86.52
See more pivots

Novartis AG - ADR Stock, NYSE:NVS

Lichtstrasse 35, Basel, Basel-Stadt (Basle Town) 4056
Phone: +41.61.324.11.11
Number of Employees: 101703


Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.